Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.

Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, Müller TH, Seltsam A.

Transfusion. 2018 May 6. doi: 10.1111/trf.14652. [Epub ahead of print]

PMID:
29732571
2.

In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens.

Eggers M, Koburger-Janssen T, Eickmann M, Zorn J.

Infect Dis Ther. 2018 Jun;7(2):249-259. doi: 10.1007/s40121-018-0200-7. Epub 2018 Apr 9.

3.

New Lineage of Lassa Virus, Togo, 2016.

Whitmer SLM, Strecker T, Cadar D, Dienes HP, Faber K, Patel K, Brown SM, Davis WG, Klena JD, Rollin PE, Schmidt-Chanasit J, Fichet-Calvet E, Noack B, Emmerich P, Rieger T, Wolff S, Fehling SK, Eickmann M, Mengel JP, Schultze T, Hain T, Ampofo W, Bonney K, Aryeequaye JND, Ribner B, Varkey JB, Mehta AK, Lyon GM 3rd, Kann G, De Leuw P, Schuettfort G, Stephan C, Wieland U, Fries JWU, Kochanek M, Kraft CS, Wolf T, Nichol ST, Becker S, Ströher U, Günther S.

Emerg Infect Dis. 2018 Mar;24(3):599-602. doi: 10.3201/eid2403.171905.

4.

Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).

Tackenberg B, Schneider M, Blaes F, Eienbröker C, Schade-Brittinger C, Wellek A, Deschauer M, Eickmann M, Klenk HD, Müller HH, Sommer N.

EBioMedicine. 2018 Feb;28:143-150. doi: 10.1016/j.ebiom.2018.01.007. Epub 2018 Jan 10.

5.

Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.

Lehmann C, Kochanek M, Abdulla D, Becker S, Böll B, Bunte A, Cadar D, Dormann A, Eickmann M, Emmerich P, Feldt T, Frank C, Fries J, Gabriel M, Goetsch U, Gottschalk R, Günther S, Hallek M, Häussinger D, Herzog C, Jensen B, Kolibay F, Krakau M, Langebartels G, Rieger T, Schaade L, Schmidt-Chanasit J, Schömig E, Schüttfort G, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M, Wieland U, Wiesmüller G, Wolf T, Fätkenheuer G.

Euro Surveill. 2017 Sep;22(39). doi: 10.2807/1560-7917.ES.2017.22.39.17-00088.

6.

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Ströher U, Nichol S, Kraft CS, Wolf T; Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2017 Sep 1;65(5):855-859. doi: 10.1093/cid/cix406.

7.

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

Rechtien A, Richert L, Lorenzo H, Martrus G, Hejblum B, Dahlke C, Kasonta R, Zinser M, Stubbe H, Matschl U, Lohse A, Krähling V, Eickmann M, Becker S; VEBCON Consortium, Thiébaut R, Altfeld M, Addo MM.

Cell Rep. 2017 Aug 29;20(9):2251-2261. doi: 10.1016/j.celrep.2017.08.023.

8.

External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa.

Ellerbrok H, Jacobsen S, Patel P, Rieger T, Eickmann M, Becker S, Günther S, Naidoo D, Schrick L, Keeren K, Targosz A, Teichmann A, Formenty P, Niedrig M.

PLoS Negl Trop Dis. 2017 May 1;11(5):e0005570. doi: 10.1371/journal.pntd.0005570. eCollection 2017 May.

9.

Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.

Siddharta A, Pfaender S, Vielle NJ, Dijkman R, Friesland M, Becker B, Yang J, Engelmann M, Todt D, Windisch MP, Brill FH, Steinmann J, Steinmann J, Becker S, Alves MP, Pietschmann T, Eickmann M, Thiel V, Steinmann E.

J Infect Dis. 2017 Mar 15;215(6):902-906. doi: 10.1093/infdis/jix046.

10.

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.

Dahlke C, Kasonta R, Lunemann S, Krähling V, Zinser ME, Biedenkopf N, Fehling SK, Ly ML, Rechtien A, Stubbe HC, Olearo F, Borregaard S, Jambrecina A, Stahl F, Strecker T, Eickmann M, Lütgehetmann M, Spohn M, Schmiedel S, Lohse AW, Becker S, Addo MM; VEBCON Consortium.

EBioMedicine. 2017 May;19:107-118. doi: 10.1016/j.ebiom.2017.03.045. Epub 2017 Apr 5.

11.

Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing.

Mengel JP, Lissin A, Biedenkopf N, Schultze T, Mannala GK, Schudt G, Kann G, Wolf T, Eickmann M, Becker S, Cemic F, Hain T.

Genome Announc. 2016 Oct 6;4(5). pii: e01011-16. doi: 10.1128/genomeA.01011-16.

12.

Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany.

Wolff S, Schultze T, Fehling SK, Mengel JP, Kann G, Wolf T, Eickmann M, Becker S, Hain T, Strecker T.

Genome Announc. 2016 Sep 22;4(5). pii: e00938-16. doi: 10.1128/genomeA.00938-16.

13.

Screening red foxes (Vulpes vulpes) for possible viral causes of encephalitis.

Bourg M, Nobach D, Herzog S, Lange-Herbst H, Nesseler A, Hamann HP, Becker S, Höper D, Hoffmann B, Eickmann M, Herden C.

Virol J. 2016 Sep 2;13(1):151. doi: 10.1186/s12985-016-0608-1.

14.

The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.

Nisii C, Vincenti D, Fusco FM, Schmidt-Chanasit J, Carbonnelle C, Raoul H, Eickmann M, Hewson R, Brave A, Nuncio S, Sanchez-Seco MP, Palyi B, Kis Z, Zange S, Nitsche A, Kurth A, Strasser M, Capobianchi MR, Ozin A, Guglielmetti P, Menel-Lemos C, Jacob D, Grunow R, Ippolito G, Di Caro A.

Clin Microbiol Infect. 2017 Feb;23(2):58-60. doi: 10.1016/j.cmi.2016.07.003. Epub 2016 Jul 9. No abstract available.

15.

Hemorrhagic Diathesis in Borrelia recurrentis Infection Imported to Germany.

Keller C, Zumblick M, Streubel K, Eickmann M, Müller D, Kerwat M, Becker S, Gress T.

Emerg Infect Dis. 2016 May;22(5):917-9. doi: 10.3201/eid2205.151557. No abstract available.

16.

Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.

Geisen C, Kann G, Strecker T, Wolf T, Schüttfort G, van Kraaij M, MacLennan S, Rummler S, Weinigel C, Eickmann M, Fehling SK, Krähling V, Seidl C, Seifried E, Schmidt M, Schäfer R.

Vox Sang. 2016 May;110(4):329-35. doi: 10.1111/vox.12376. Epub 2016 Jan 14.

PMID:
26766162
17.

Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus.

Krähling V, Becker D, Rohde C, Eickmann M, Eroğlu Y, Herwig A, Kerber R, Kowalski K, Vergara-Alert J, Becker S; European Mobile Laboratory consortium.

Med Microbiol Immunol. 2016 Apr;205(2):173-83. doi: 10.1007/s00430-015-0438-6. Epub 2015 Oct 16.

PMID:
26475282
18.
20.

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

Malczyk AH, Kupke A, Prüfer S, Scheuplein VA, Hutzler S, Kreuz D, Beissert T, Bauer S, Hubich-Rau S, Tondera C, Eldin HS, Schmidt J, Vergara-Alert J, Süzer Y, Seifried J, Hanschmann KM, Kalinke U, Herold S, Sahin U, Cichutek K, Waibler Z, Eickmann M, Becker S, Mühlebach MD.

J Virol. 2015 Nov;89(22):11654-67. doi: 10.1128/JVI.01815-15. Epub 2015 Sep 9.

21.

Shedding of Infectious Borna Disease Virus-1 in Living Bicolored White-Toothed Shrews.

Nobach D, Bourg M, Herzog S, Lange-Herbst H, Encarnação JA, Eickmann M, Herden C.

PLoS One. 2015 Aug 27;10(8):e0137018. doi: 10.1371/journal.pone.0137018. eCollection 2015.

22.

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.

Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, Kaya G, Krähling V, Kwilas S, Lemaître B, Matthey A, Silvera P, Becker S, Fast PE, Moorthy V, Kieny MP, Kaiser L, Siegrist CA; VSV-Ebola Consortium.

Lancet Infect Dis. 2015 Oct;15(10):1156-1166. doi: 10.1016/S1473-3099(15)00154-1. Epub 2015 Aug 4.

PMID:
26248510
23.

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.

Volz A, Kupke A, Song F, Jany S, Fux R, Shams-Eldin H, Schmidt J, Becker C, Eickmann M, Becker S, Sutter G.

J Virol. 2015 Aug;89(16):8651-6. doi: 10.1128/JVI.00614-15. Epub 2015 May 27.

24.

Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency.

Strecker T, Palyi B, Ellerbrok H, Jonckheere S, de Clerck H, Bore JA, Gabriel M, Stoecker K, Eickmann M, van Herp M, Formenty P, Di Caro A, Becker S.

Clin Infect Dis. 2015 Sep 1;61(5):669-75. doi: 10.1093/cid/civ397. Epub 2015 May 19.

25.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, Adegnika AA, Altfeld M, Auderset F, Bache EB, Biedenkopf N, Borregaard S, Brosnahan JS, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling SK, Finckh A, Goncalves AR, Grobusch MP, Hooper J, Jambrecina A, Kabwende AL, Kaya G, Kimani D, Lell B, Lemaître B, Lohse AW, Massinga-Loembe M, Matthey A, Mordmüller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl FR, Staines HM, Strecker T, Stubbe HC, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny MP, Bejon P, Kremsner PG, Addo MM, Siegrist CA.

N Engl J Med. 2016 Apr 28;374(17):1647-60. doi: 10.1056/NEJMoa1502924. Epub 2015 Apr 1.

26.

Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication.

Dickmann P, Apfel F, Biedenkopf N, Eickmann M, Becker S.

Health Secur. 2015 Mar-Apr;13(2):88-95. Epub 2015 Mar 20.

PMID:
25813975
27.

Extracorporeal virus elimination for the treatment of severe Ebola virus disease--first experience with lectin affinity plasmapheresis.

Büttner S, Koch B, Dolnik O, Eickmann M, Freiwald T, Rudolf S, Engel J, Becker S, Ronco C, Geiger H.

Blood Purif. 2014;38(3-4):286-91. doi: 10.1159/000375229. Epub 2015 Feb 11.

28.

[Therapeutic use of immune sera. Ebola survivors as lifesavers?].

Eickmann M, Schumacher B.

MMW Fortschr Med. 2014 Nov 6;156(19):6. German. No abstract available.

PMID:
25509993
29.

Risk communication and crisis communication in infectious disease outbreaks in Germany: what is being done, and what needs to be done.

Dickmann P, Biedenkopf N, Keeping S, Eickmann M, Becker S.

Disaster Med Public Health Prep. 2014 Jun;8(3):206-11. doi: 10.1017/dmp.2014.36. Epub 2014 May 7.

PMID:
24804970
30.

Landscape features and reservoir occurrence affecting the risk for equine infection with Borna disease virus.

Encarnação JA, Herzog S, Eickmann M, Becker NI, Hermes N, Herden C.

J Wildl Dis. 2013 Oct;49(4):860-8. doi: 10.7589/2012-10-262.

PMID:
24502713
31.

Bicolored white-toothed shrews as reservoir for borna disease virus, Bavaria, Germany.

Bourg M, Herzog S, Encarnação JA, Nobach D, Lange-Herbst H, Eickmann M, Herden C.

Emerg Infect Dis. 2013 Dec;19(12):2064-6. doi: 10.3201/eid1912.131076. No abstract available.

32.

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.

Song F, Fux R, Provacia LB, Volz A, Eickmann M, Becker S, Osterhaus AD, Haagmans BL, Sutter G.

J Virol. 2013 Nov;87(21):11950-4. doi: 10.1128/JVI.01672-13. Epub 2013 Aug 28.

33.

Synthetic generation of influenza vaccine viruses for rapid response to pandemics.

Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, Dattilo BM, Denisova EA, De Souza I, Eickmann M, Dugan VG, Ferrari A, Gomila RC, Han L, Judge C, Mane S, Matrosovich M, Merryman C, Palladino G, Palmer GA, Spencer T, Strecker T, Trusheim H, Uhlendorff J, Wen Y, Yee AC, Zaveri J, Zhou B, Becker S, Donabedian A, Mason PW, Glass JI, Rappuoli R, Venter JC.

Sci Transl Med. 2013 May 15;5(185):185ra68. doi: 10.1126/scitranslmed.3006368.

34.

Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China.

Corman VM, Eickmann M, Landt O, Bleicker T, Brünink S, Eschbach-Bludau M, Matrosovich M, Becker S, Drosten C.

Euro Surveill. 2013 Apr 18;18(16):20461.

35.

Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus.

Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M, Becker S, Weber F.

J Virol. 2013 May;87(9):5300-4. doi: 10.1128/JVI.03496-12. Epub 2013 Feb 28.

36.

Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.

Nisii C, Castilletti C, Raoul H, Hewson R, Brown D, Gopal R, Eickmann M, Gunther S, Mirazimi A, Koivula T, Feldmann H, Di Caro A, Capobianchi MR, Ippolito G.

PLoS Pathog. 2013 Jan;9(1):e1003105. doi: 10.1371/journal.ppat.1003105. Epub 2013 Jan 17. No abstract available.

37.

Borna disease virus infection of a horse in Great Britain.

Priestnall SL, Schöniger S, Ivens PA, Eickmann M, Brachthäuser L, Kehr K, Tupper C, Piercy RJ, Menzies-Gow NJ, Herden C.

Vet Rec. 2011 Apr 9;168(14):380b. doi: 10.1136/vr.c6405. Epub 2011 Mar 2. No abstract available.

PMID:
21498268
38.

Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens.

Strecker T, Uhlendorff J, Diederich S, Lenz-Bauer C, Trusheim H, Roth B, Kolesnikova L, Aepinus C, Dornow R, Gerlach J, Matrosovich M, Valley U, Eickmann M, Becker S.

Clin Chem Lab Med. 2012 May 23;50(7):1275-9. doi: 10.1515/cclm-2011-0650.

PMID:
22850059
39.

Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set.

Wenzel JJ, Panning M, Kaul KL, Mangold KA, Revell PA, Luna RA, Zepeda H, Perea L, Vazquez-Perez JA, Young S, Rodic-Polic B, Eickmann M, Drosten C, Jilg W, Reischl U.

J Clin Microbiol. 2010 Sep;48(9):3088-94. doi: 10.1128/JCM.00785-10. Epub 2010 Jul 7.

40.

Fatal cowpox virus infection in captive banded mongooses (Mungos mungo).

Schmiedeknecht G, Eickmann M, Köhler K, Herden CE, Kolesnikova L, Förster C, Burkhardt EH, König M, Thiel M, Reinacher M.

Vet Pathol. 2010 May;47(3):547-52. doi: 10.1177/0300985810363703.

PMID:
20472807
41.

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors.

Böttcher-Friebertshäuser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, Uhlendorff J, Steinmetzer T, Klenk HD, Garten W.

J Virol. 2010 Jun;84(11):5605-14. doi: 10.1128/JVI.00140-10. Epub 2010 Mar 17.

42.

European perspective of 2-person rule for biosafety level 4 laboratories.

Ippolito G, Nisii C, Di Caro A, Brown D, Gopal R, Hewson R, Lloyd G, Gunther S, Eickmann M, Mirazimi A, Koivula T, Georges Courbot MC, Raoul H, Capobianchi MR.

Emerg Infect Dis. 2009 Nov;15(11):1858. doi: 10.3201/eid1511.091134. No abstract available.

43.

Detection of influenza A(H1N1)v virus by real-time RT-PCR.

Panning M, Eickmann M, Landt O, Monazahian M, Olschläger S, Baumgarte S, Reischl U, Wenzel JJ, Niller HH, Günther S, Hollmann B, Huzly D, Drexler JF, Helmer A, Becker S, Matz B, Eis-Hübinger A, Drosten C.

Euro Surveill. 2009 Sep 10;14(36). pii: 19329.

44.

Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray.

Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, Campanero-Rhodes MA, Zhang Y, Eickmann M, Kiso M, Hay A, Matrosovich M, Feizi T.

Nat Biotechnol. 2009 Sep;27(9):797-9. doi: 10.1038/nbt0909-797. No abstract available. Erratum in: Nat Biotechnol. 2010 Feb;28(2):178.

45.

[Hospital hygiene - Influenza].

Kerwat K, Eickmann M, Becker S, Wulf H.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Jun;44(6):418-9. doi: 10.1055/s-0029-1225749. Epub 2009 Jun 12. Review. German.

PMID:
19526445
46.

Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris.

Nagel A, Podstawa E, Eickmann M, Müller HH, Hertl M, Eming R.

J Invest Dermatol. 2009 Sep;129(9):2202-10. doi: 10.1038/jid.2009.27. Epub 2009 Mar 12.

47.

Implications for a regulated replication of Borna disease virus in brains of experimentally infected Lewis rats.

Porombka D, Baumgärtner W, Eickmann M, Herden C.

Virus Genes. 2008 Apr;36(2):415-20. doi: 10.1007/s11262-008-0210-8. Epub 2008 Feb 14.

PMID:
18273698
48.

Blood screening for influenza.

Hourfar MK, Themann A, Eickmann M, Puthavathana P, Laue T, Seifried E, Schmidt M.

Emerg Infect Dis. 2007 Jul;13(7):1081-3. doi: 10.3201/eid1307.060861.

49.

Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories.

Panning M, Laue T, Olschlager S, Eickmann M, Becker S, Raith S, Courbot MC, Nilsson M, Gopal R, Lundkvist A, di Caro A, Brown D, Meyer H, Lloyd G, Kummerer BM, Gunther S, Drosten C.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S199-204.

PMID:
17940950
50.

Characterization of severe acute respiratory syndrome coronavirus membrane protein.

Voss D, Kern A, Traggiai E, Eickmann M, Stadler K, Lanzavecchia A, Becker S.

FEBS Lett. 2006 Feb 6;580(3):968-73. Epub 2006 Jan 19.

Supplemental Content

Loading ...
Support Center